GSK Institutional Ownership & Shareholders

GSK PLC-SPON ADR (GSK) is currently held by 1,011 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $17.92B based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Fmr Llc is currently the largest disclosed institutional shareholder of GSK tracked by InsiderSet, reporting ownership valued at approximately $3.41B in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $3.22B, representing an estimated loss of -5.55% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 65% of the total disclosed GSK value among the investors covered in this analysis. Major shareholders include Fmr Llc, Dodge & Cox Stock Fund, Fisher Asset Management, Llc, and several other long-term asset managers with concentrated positions in GSK PLC-SPON ADR (GSK).

This page ranks the largest institutional GSK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

1,011

Total Reported Value

$17.92B

Largest Holder

Fmr Llc

Largest Position

$3.41B

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

25

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.15%64,961,641$3,405,289,251$3,216,250,846-$189,038,405-5.55%
Dodge & Cox Stock FundV. D. Dodge, E. M. Cox1.32%48,197,514$2,526,513,684$2,386,258,918-$140,254,766-5.55%
Fisher Asset Management, Llc0.56%35,722,792$1,872,588,820$1,768,635,432-$103,953,388-5.55%
Primecap Management Co/Ca/0.78%25,182,068$1,320,044,006$1,246,764,187-$73,279,819-5.55%
Wellington Management Group Llp0.10%11,396,249$597,391,372$564,228,288-$33,163,084-5.55%
Jtc Employer Solutions Trustee Ltd36.11%8,592,987$450,315,000$425,438,786-$24,876,214-5.52%
Morgan Stanley0.02%7,657,562$401,409,572$379,125,895-$22,283,677-5.55%
Royal Bank Of Canada0.07%7,588,928$397,813,000$375,727,825-$22,085,175-5.55%
Price T Rowe Associates Inc0.04%6,923,642$362,938,000$342,789,515-$20,148,485-5.55%
Acadian Asset Management Llc0.41%6,660,434$349,109,000$329,758,087-$19,350,913-5.54%
Goldman Sachs Group Inc0.04%6,371,442$333,990,989$315,450,093-$18,540,896-5.55%
State Street Corp0.01%5,959,115$315,143,229$295,035,784-$20,107,445-6.38%
Mondrian Investment Partners Ltd4.44%4,965,946$239,209,625$245,863,986+$6,654,361+2.78%
Bank Of Montreal0.08%4,042,863$211,926,879$200,162,147-$11,764,732-5.55%
Blackrock, Inc.0.00%3,620,294$189,775,819$179,240,756-$10,535,063-5.55%
Grantham, Mayo, Van Otterloo & Co. Llc0.43%3,599,521$188,686,891$178,212,285-$10,474,606-5.55%
Hotchkis & Wiley Capital Management Llc0.52%3,413,574$178,939,549$169,006,049-$9,933,500-5.55%
Equity Investment Corp3.27%3,269,765$171,401,067$161,886,065-$9,515,002-5.55%
Ubs Group Ag0.02%2,806,205$147,101,266$138,935,210-$8,166,056-5.55%
Connor, Clark & Lunn Investment Management Ltd.0.27%2,767,591$145,077,121$137,023,430-$8,053,691-5.55%
Dimensional Fund Advisors Lp0.03%2,691,698$141,098,816$133,265,968-$7,832,848-5.55%
Point72 Asset Management, L.P.0.21%2,652,881$139,064,022$131,344,138-$7,719,884-5.55%
Bank Of America Corp0.01%2,216,888$116,209,277$109,758,125-$6,451,152-5.55%
Jpmorgan Chase & Co0.01%2,085,014$110,109,683$103,229,043-$6,880,640-6.25%
Envestnet Asset Management Inc0.02%1,908,549$100,044,669$94,492,261-$5,552,408-5.55%
Manufacturers Life Insurance Company, The0.08%1,887,739$98,955,252$93,461,958-$5,493,294-5.55%
American Century Companies Inc0.04%1,838,479$96,373,069$91,023,095-$5,349,974-5.55%
Northern Trust Corp0.01%1,754,564$91,974,245$86,868,464-$5,105,781-5.55%
Arrowstreet Capital, Limited Partnership0.04%1,633,029$85,603,380$80,851,266-$4,752,114-5.55%
Letko, Brosseau & Associates Inc1.26%1,624,668$85,165,097$80,437,313-$4,727,784-5.55%
Brandes Investment Partners, Lp0.55%1,483,198$77,750,479$73,433,133-$4,317,346-5.55%
Aristotle Capital Management, Llc0.16%1,463,518$76,719,824$72,458,776-$4,261,048-5.55%
Raymond James Financial Inc0.02%1,396,694$73,214,731$69,150,320-$4,064,411-5.55%
Wells Fargo & Company/Mn0.01%1,361,227$71,355,523$67,394,349-$3,961,174-5.55%
Bnp Paribas Financial Markets0.04%1,313,691$68,863,682$65,040,841-$3,822,841-5.55%
Mariner, Llc0.07%1,285,362$67,379,475$63,638,273-$3,741,202-5.55%
Sei Investments Co0.06%1,250,431$65,547,932$61,908,839-$3,639,093-5.55%
Miller Howard Investments Inc1.52%1,174,089$56,555,871$58,129,146+$1,573,275+2.78%
Qube Research & Technologies Ltd0.06%1,078,767$56,548,966$53,409,754-$3,139,212-5.55%
Russell Investments Group, Ltd.0.05%1,038,101$54,417,237$51,396,381-$3,020,856-5.55%
D. E. Shaw & Co., Inc.0.03%1,019,449$53,439,517$50,472,920-$2,966,597-5.55%
Lmr Partners Llp0.38%980,479$51,396,709$48,543,515-$2,853,194-5.55%
Callodine Capital Management, Lp3.38%979,740$51,357,971$48,506,927-$2,851,044-5.55%
Newedge Advisors, Llc0.15%953,574$49,986,404$47,211,449-$2,774,955-5.55%
Lpl Financial Llc0.01%917,107$48,074,726$45,405,968-$2,668,758-5.55%
Bank Of New York Mellon Corp0.01%838,769$43,968,305$41,527,453-$2,440,852-5.55%
Van Eck Associates Corp0.03%787,508$41,281,169$38,989,521-$2,291,648-5.55%
Douglas Lane & Associates, Llc0.48%749,690$36,112,574$37,117,152+$1,004,578+2.78%
Stifel Financial Corp0.03%642,212$33,664,786$31,795,916-$1,868,870-5.55%
First Trust Advisors Lp0.02%640,635$33,582,031$31,717,839-$1,864,192-5.55%
Showing 50 of 1,011

Frequently asked questions about GSK

  • Who are the largest institutional holders of GSK?

    The largest institutional holders of GSK reported in the latest SEC Form 13F filings include Fmr Llc, Dodge & Cox Stock Fund, Fisher Asset Management, Llc, Primecap Management Co/Ca/, and Wellington Management Group Llp. InsiderSet ranks institutional holders by their latest reported GSK position.

  • What is GSK institutional ownership?

    This page tracks GSK positions reported by institutional investment managers through SEC Form 13F. GSK PLC-SPON ADR (GSK) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own GSK?

    InsiderSet currently tracks 1,011 institutional managers reporting GSK holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of GSK shareholders.

  • How much GSK stock do institutions own?

    Institutional investment managers disclosed approximately $17.92B in GSK holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was GSK institutional ownership last updated?

    The latest GSK institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional GSK holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its GSK position after the reporting date.

  • Are institutions buying or selling GSK?

    Institutional buying and selling can be analyzed by comparing GSK positions across consecutive 13F reporting periods. InsiderSet's GSK Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View GSK ownership changes.

  • How has GSK institutional ownership changed over time?

    InsiderSet tracks GSK institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.